Inception Therapeutics
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
38-11 Place Du Commerce Ste 195, Verdun,...Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Inception Therapeutics
Inception Therapeutics (ITI) was incorporated in 2013 and is located in Montréal, Canada. ITI is a spin off from University of Montreals Centre Hospitalier Universitaire Sainte-Justines (CHU Sainte-Justine) Research Center. The company recently secured a global license for the development and marketing rights of an early osteoarthritis (OA) diagnostic test and small molecule therapeutics. ITI is focussed at better understanding the Molecular Genetics involved at the inception of diseases to find novel Diagnostics and Therapeutic solutions. The company is targeting chronic and disabling adult and pediatric diseases such as osteoarthritis, muscular dystrophy and other musculoskeletal related diseases. ITIs business model is based on maximizing value creation during the development phases of its diagnostic tests and small molecule therapeutics and to ultimately out-license its therapeutics and companion diagnostic tests to a major pharmaceutical, biotechnology or diagnostic tests companieRead more
Popular SearchesInception TherapeuticsInception Therapeutic IncInception Therapeutics IncInceptiontherapeuticsSIC Code 87,873NAICS Code 54,541Show more
Inception Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Inception Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Inception Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Inception Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Inception Therapeutics
Product Launch: Get notified when Inception Therapeutics launches new products
Earning: See what the market has to say on Inception Therapeutics recently announced quarterly report
Check out if Inception Therapeutics is spiking on competitors!
Click to see if Inception Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Inception Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Inception Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Inception Therapeutics
Compare insights from companies similar to Inception Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Inception Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Inception Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Inception Therapeutics.
Inception Therapeutics Tech Stack
A closer look at the technologies used by Inception Therapeutics
See more technologies
Top Business Services Companies
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Inception Therapeutics
Sign Up For FreeTo access detailed company insights
Inception Therapeutics (ITI) was incorporated in 2013 and is located in Montréal, Canada. ITI is a spin off from University of Montreals Centre Hospitalier Universitaire Sainte-Justines (CHU Sainte-Justine) Research Center. The company recently secured a global license for the development and marketing rights of an early osteoarthritis (OA) diagnos... Read More
